GE HealthCare Launches AI-Powered CareIntellect for Oncology

GE HealthCare has launched a new AI-powered application, CareIntellect for Oncology, designed to provide clinicians with a comprehensive view of a patient’s journey in a single, easy-to-navigate interface. The cloud-based platform aims to simplify how care teams access multi-modal patient data, allowing for quicker and more informed decision-making.

A Solution for Proactive Oncology Care

CareIntellect for Oncology goes beyond simple data aggregation by leveraging generative AI to organize and summarize complex medical histories, including structured and unstructured data like medical images, records, notes, and device readings. This allows care teams to quickly assess disease progression, monitor treatment adherence, and spot any deviations from a treatment plan, all within one interface.

Initially focusing on prostate and breast cancer, the application will help clinicians track treatment response, assess clinical trial eligibility, and proactively intervene when needed. By bringing together disparate data sources, CareIntellect drastically reduces the time clinicians spend searching for critical patient information, a process that traditionally takes hours.

Early Evaluation and Broader Availability

Tampa General Hospital and UT Southwestern Medical Center will be early evaluators of the CareIntellect for Oncology platform. GE HealthCare plans to make the application available to U.S. customers in 2025, with further expansion planned for Canada, the UK, and Ireland.

Streamlining Clinical Workflows

CareIntellect’s primary focus is to address the growing cognitive burden on clinicians. Today, doctors spend substantial time combing through siloed information across various systems to make informed treatment decisions. This time-intensive process can negatively impact patient care, especially in oncology, where treatment journeys are long and complex. For example, matching patients to suitable clinical trials often requires sifting through vast amounts of data, a process that 80% of oncologists find overwhelming.

By summarizing and flagging relevant data, CareIntellect enables care teams to reduce these time-consuming tasks to just minutes. It also helps clinicians spot deviations in patient treatment plans that may otherwise go unnoticed, such as missed lab work that could delay critical treatments.

Timely Launch for Breast Cancer Awareness Month

The launch of CareIntellect for Oncology is especially timely, coinciding with Breast Cancer Awareness Month in October. With its initial focus on breast and prostate cancer, the platform offers healthcare providers powerful AI tools to enhance care for breast cancer patients. As awareness grows around early detection and effective treatment, innovations like CareIntellect aim to support clinicians in delivering the most informed and proactive care possible.

Feedback from Early Evaluators

Dr. Peter Chang, Senior Vice President and Chief Transformation Officer at Tampa General Hospital, praised the potential of CareIntellect for Oncology. "We were impressed by how quickly GE HealthCare was able to design the application to include breast cancer in a matter of weeks. We look forward to putting this in the hands of our care teams and using the AI-enabled functionality to help clinicians spend time where it matters most—delivering outstanding patient care," he said.

A New Era of AI-Driven Healthcare

CareIntellect for Oncology is the first in a series of applications under GE HealthCare’s new CareIntellect platform. Built on a cloud-first infrastructure, CareIntellect is designed to minimize integration burdens for healthcare providers, allowing them to onboard new applications without the costly and time-consuming process of product-by-product integration. The platform is compatible with existing single sign-on systems, offering seamless access to data and capabilities that enhance both clinical and operational efficiency.

"Currently, only 3% of hospital data is used because of the complexities associated with organizing and extracting useful healthcare insights at scale," said Dr. Taha Kass-Hout, Global Chief Science and Technology Officer at GE HealthCare. "CareIntellect is designed to help providers streamline access to critical patient information and surface key changes since the patient’s last visit."

With this AI-powered platform, GE HealthCare aims to accelerate digital transformation in hospitals, helping care teams spend more time with patients and less time on manual data searches. To learn more about these solutions and see a demo, visit their website. 

What This Means for AI in Healthcare

The introduction of CareIntellect for Oncology signals a growing trend of AI transforming how healthcare providers manage patient care. By simplifying the retrieval and analysis of multi-modal data, AI-driven platforms like this one can reduce clinician workload and improve patient outcomes through more timely interventions. As AI becomes more integrated into clinical workflows, we can expect faster, more personalized care, along with increased access to advanced treatments and clinical trials — reshaping the future of oncology and other medical fields.